Your cart:$0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Dutasteride - Avodart

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Avodart

Generic Avodart

Dutasteride 0.5mg

Generic Avodart is used for treating symptoms of benign prostatic hyperplasia (BPH) or enlargement of the prostate gland. It also helps to reduce the risk of urinary blockage and the need for prostate surgery.

More info »
$0.83 Buy now!
Choose Your language:
Social bookmarks:
Testimonials
your shipment arrived this morning, tnks i am very happy with your reliable service.
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

Dutasteride May Decrease Risk of BPH Clinical Progression - Renal and Urology News
Dutasteride May Decrease Risk of BPH Clinical ProgressionRenal and Urology NewsATLANTA—Men with enlarged prostates may be able to decrease the likelihood of clinical progression of their condition by taking dutasteride, according to study findings presented at the American Urological Association 2012 annual meeting
Some Cholesterol Drugs May Slow Prostate Growth - WebMD
Daily MailSome Cholesterol Drugs May Slow Prostate GrowthWebMDMuller and his team used data from a large study of the drug Avodart (dutasteride), which is prescribed to treat benign prostate hyperplasia (BPH), a noncancerous enlargement of the prostate
Coronary Artery Disease May Boost Risk of Prostate Cancer - OncLive
OncLiveCoronary Artery Disease May Boost Risk of Prostate CancerOncLiveThe 4-year, phase III REDUCE study evaluated the 5α-reductase inhibitor dutasteride, 0
New Therapy Is Essential for Men with Prostate Enlargement As Medications Have ... - Seattle Post Intelligencer
New Therapy Is Essential for Men with Prostate Enlargement As Medications Have
5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active Surveillance - OncLive
OncLive5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active SurveillanceOncLiveHe added that these findings are supported by the double-blind, placebo-controlled Reduction by Dutasteride of Clinical Progression Events in Expectant Management of Prostate Cancer (REDEEM) trial, which was recently published in The Lancet
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News